13,401
Total Claims
$1.5M
Drug Cost
1,141
Beneficiaries
$1,339
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-12%
Cost per patient vs peers
$1,339 vs $1,524 avg
-14%
Brand preference vs peers
11.7% vs 13.7% avg
Brand vs Generic
88% generic
Brand: 1,567 claims · $1.3M
Generic: 11,834 claims · $221K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 894 | $857K |
| Sacubitril/Valsartan | 151 | $153K |
| Rivaroxaban | 88 | $83K |
| Evolocumab | 88 | $69K |
| Ezetimibe | 1,590 | $39K |
| Ticagrelor | 39 | $28K |
| Icosapent Ethyl | 47 | $28K |
| Alirocumab | 44 | $27K |
| Dapagliflozin Propanediol | 28 | $16K |
| Pravastatin Sodium | 697 | $16K |
| Atorvastatin Calcium | 1,080 | $15K |
| Icosapent Ethyl | 21 | $14K |
| Rosuvastatin Calcium | 830 | $13K |
| Clopidogrel Bisulfate | 775 | $10K |
| Metoprolol Succinate | 620 | $8,758 |
Prescribing Profile
63
Unique Drugs
$1.1M
Patient Profile
76
Avg Age
49%
Female
1.43
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data